Hayden Royal LLC Purchases New Holdings in Aurora Cannabis Inc (NYSE:ACB)

Hayden Royal LLC purchased a new stake in shares of Aurora Cannabis Inc (NYSE:ACB) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 10,485 shares of the company’s stock, valued at approximately $75,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Actinver Wealth Management Inc. increased its position in shares of Aurora Cannabis by 6.4% during the first quarter. Actinver Wealth Management Inc. now owns 20,090 shares of the company’s stock valued at $182,000 after acquiring an additional 1,215 shares during the last quarter. Glassman Wealth Services boosted its stake in shares of Aurora Cannabis by 8.2% during the first quarter. Glassman Wealth Services now owns 17,587 shares of the company’s stock valued at $159,000 after purchasing an additional 1,326 shares in the last quarter. Moloney Securities Asset Management LLC boosted its stake in Aurora Cannabis by 13.9% in the first quarter. Moloney Securities Asset Management LLC now owns 12,320 shares of the company’s stock valued at $112,000 after acquiring an additional 1,500 shares in the last quarter. Truvestments Capital LLC boosted its stake in Aurora Cannabis by 3.3% in the second quarter. Truvestments Capital LLC now owns 46,344 shares of the company’s stock valued at $362,000 after acquiring an additional 1,500 shares in the last quarter. Finally, Focused Wealth Management Inc boosted its stake in Aurora Cannabis by 33.6% in the first quarter. Focused Wealth Management Inc now owns 6,574 shares of the company’s stock valued at $60,000 after acquiring an additional 1,654 shares in the last quarter. 9.10% of the stock is owned by institutional investors.

Shares of Aurora Cannabis stock traded down $0.31 during trading on Thursday, hitting $5.78. 10,216,990 shares of the company’s stock were exchanged, compared to its average volume of 14,332,165. The company has a quick ratio of 1.98, a current ratio of 2.37 and a debt-to-equity ratio of 0.10. The firm’s 50-day simple moving average is $6.90. Aurora Cannabis Inc has a 52-week low of $4.45 and a 52-week high of $12.52. The company has a market cap of $6.70 billion, a PE ratio of 48.20 and a beta of 2.44.

Aurora Cannabis (NYSE:ACB) last issued its earnings results on Tuesday, May 14th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.03) by ($0.05). Aurora Cannabis had a positive return on equity of 1.24% and a negative net margin of 122.65%. The business had revenue of $49.00 million for the quarter, compared to analysts’ expectations of $50.92 million. Sell-side analysts forecast that Aurora Cannabis Inc will post -0.23 EPS for the current year.

Several equities research analysts have weighed in on the stock. LADENBURG THALM/SH SH assumed coverage on shares of Aurora Cannabis in a research note on Wednesday, July 17th. They issued a “buy” rating and a $9.00 target price for the company. Piper Jaffray Companies assumed coverage on shares of Aurora Cannabis in a research note on Monday. They issued a “neutral” rating and a $7.00 target price for the company. Stifel Nicolaus started coverage on shares of Aurora Cannabis in a research note on Wednesday, June 5th. They issued a “hold” rating for the company. Bank of America downgraded shares of Aurora Cannabis from a “buy” rating to a “neutral” rating and set a $7.30 price objective for the company. in a research note on Thursday, July 18th. Finally, Zacks Investment Research upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating and set a $7.50 price objective for the company in a research note on Thursday, August 8th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $8.23.

Aurora Cannabis Profile

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Further Reading: What is included in the gross domestic product?

Institutional Ownership by Quarter for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.